UK PM: Playing fair on AstraZeneca deal

Comment on this story
Pfizer1 Reuters. US drugmaker Pfizer.

London - Britain's leader sought to deflect criticism that he's been working too closely with US drugmaker Pfizer in its proposed $106-billion takeover of the Anglo-Swedish firm AstraZeneca.

With fears growing that British jobs will be lost and the nation's science base undermined in the potential merger, Prime Minister David Cameron denied in a BBC interview Sunday that he was favouring the American company.

When asked on The Andrew Marr Show whether he was engaging more closely with Pfizer, Cameron insisted that was not the case.

Cameron said “ministers were talking to AstraZeneca before anyone spoke to Pfizer.”

Pfizer has been trying to buy AstraZeneca since January, but has been rebuffed three times.

The proposed deal would be the largest foreign takeover of a British company. - Sapa-AP

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines